GO
Loading...

Takeover Bids

More

  • Nov 17- Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.. Besides the higher price tag, the Actavis deal came with only $400 million in R&D cuts for Allergan, far less than the $900 million decrease...

  • Ahead of the Bell: Allergan soars on deal reports Monday, 17 Nov 2014 | 7:38 AM ET

    Shares of Allergan jumped in premarket trading Monday after several reports surfaced over the weekend that specialty drugmaker Actavis was preparing to buy the Botox maker, which is fighting off a separate takeover bid from Valeant Pharmaceuticals. The New York Times reported that Allergan is nearing a deal to sell itself to Actavis for more than $62.5...

  • LISBON, Nov 11- Angolan investor Isabel dos Santos said on Tuesday she was willing to change the terms of her bid to buy Portugal Telecom if necessary, to prevent Brazil's Oi from selling PT's assets to a rival party. Dos Santos launched the bid for Portugal Telecom, a holding company with a 25.6 percent stake in the combined Oi-PT company, partly in an attempt to...

  • LISBON, Nov 11- Brazil telecom company Oi issued a tough rejection of a bid for its merger partner Portugal Telecom on Tuesday, saying Angolan entrepreneur Isabel dos Santos' offer, which would prevent Oi from selling assets to a rival party, was "unacceptable." Dos Santos launched the bid for Portugal Telecom, a holding company with a 25.7 percent stake in the...

  • LISBON, Nov 10- Brazilian telecom company Oi said on Monday it would push ahead with plans to take over the operational assets of Portugal Telecom, dismissing a gambit by Angolan businesswoman Isabel dos Santos that could scupper the deal. Oi announced last year a deal to merge with Portugal Telecom's phone and cable TV networks. But dos Santos, who is listed by...

  • European shares inch up; M&A boosts Fugro, Nutreco Monday, 10 Nov 2014 | 4:12 AM ET

    *Nutreco rises as SHV sweetens takeover offer. *Fugro jumps after rival buys 15 pct stake. PARIS, Nov 10- European stocks inched higher early on Monday, reversing some of the previous session's losses, with Nutreco surging 14 percent as SHV sweetened its takeover bid for the Dutch animal feed and nutrition company.

  • PARIS, Nov 10- European stocks were steady at the open on Monday, taking a breather after the previous session's losses, with Nutreco surging 13 percent as SHV sweetened its takeover bid for the Dutch animal feed and nutrition company. At 0808 GMT, the FTSEurofirst 300 index of top European shares was up 0.1 percent at 1,346.70 points. Carlsberg gained 3.3 percent...

  • LONDON, Nov 6- Recent U.S. tax changes have weakened the case for companies like Pfizer to shift their tax bases overseas by striking so-called tax inversion deals, according to AstraZeneca's chief executive. AstraZeneca fended off a $118 billion takeover bid from its larger U.S. rival in May but there is speculation Pfizer may return after Nov. 26, when it is...

  • LONDON, Nov 6- AstraZeneca raised its 2014 sales forecast for the second quarter in a row on Thursday, as the delayed arrival of generic copies of its Nexium drug in the United States kept cash flowing from the heartburn and ulcer pill. Britain's second biggest drugmaker, which saw off a $118 billion takeover bid from Pfizer in May, now expects revenue to grow in low...

  • Nov 4- A federal judge on Tuesday cleared the way for Pershing Square Capital Management and Valeant Pharmaceuticals International Inc to vote at an Allergan Inc shareholder meeting where they are seeking to remove six of nine Allergan board members as part of a hostile takeover attempt. The companies offered in April to buy Allergan in a cash-and-stock bid...

  • Time Warner's HBO to cut 7 percent of staff Tuesday, 28 Oct 2014 | 12:28 PM ET

    Oct 28- Time Warner Inc's pay TV network HBO is preparing to cut 7 percent of its staff in the United States or about 150 jobs. Time Warner, under pressure to boost profits after rejecting a takeover bid, has also announced cuts at its other units: cable networks Turner Broadcasting and movie studio Warner Bros. Time Warner is under pressure to boost its stock price...

  • NEW YORK, Oct 28- Investors stung by plunging oil prices and energy stocks may find relief right around the corner: A Republican-led U.S. Senate could well jump-start energy-friendly policies that would shore up the beaten-down sector. Now, those with a stake in the sector hope a Republican Senate takeover will lead to reform of export laws, speed up approval of...

  • Oct 27- Valeant Pharmaceuticals International Inc said it was prepared to raise its cash-and-stock offer for Allergan Inc to at least $200 per share. An offer of $200 per share offer would value Allergan at $59.44 billion. Valeant CEO Michael Pearson said in a letter to Allergan's board that Allergan's stock would not be trading at the multiples it is now if it...

  • Oct 24- Banana producer Chiquita Brands International Inc said it would start takeover talks with Brazil's Grupo Cutrale and Safra Group after its shareholders voted against a proposed merger with Irish rival Fyffes Plc. Fyffes' shares fell 5 percent to 94 euro cents in Dublin after the collapse of the deal, which would have created a company domiciled in...

  • Oct 24- Banana producer Chiquita Brands International Inc said it would start takeover talks with Brazil's Grupo Cutrale and Safra Group after its shareholders voted against its proposed merger with Irish rival Fyffes Plc. Fyffes' shares were down 9 percent at 90 euro cents in Dublin. Fyffes and Chiquita said recently that the implied value of their potential...

  • Investing on speculation     Wednesday, 22 Oct 2014 | 3:28 PM ET

    Leigh Drogen, Estimize CEO, discusses his "Mergerize" platform, and CNBC contributor Herb Greenberg, discuss if it is ever a good idea to invest in a company based on takeover speculation.

  • BOSTON, Oct 20- Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was making a hostile takeover bid, court documents showed. Ackman's hedge fund has been working with Valeant for months to craft a...

  • Oct 20- Valeant Pharmaceuticals Inc Chief Executive Michael Pearson said in an interview with Reuters on Monday that he is confident a revised bid for Allergan Inc will be worth over $200 per share, once Valeant's stock rises and with cash added to the offer. Pearson said Valeant could make a revised offer at any time and that the company's stock has been hurt by...

  • Valeant's bid for Allergan     Monday, 20 Oct 2014 | 7:22 AM ET

    Michael Pearson, Valeant Pharmaceuticals CEO, shares his thoughts on allegations Allergan released false and misleading information.

  • Oct 17- Activist investor Elliott Advisors UK Ltd nominated seven candidates for election to Family Dollar Stores Inc's board as it looks to push for a sale of the dollar store operator to bigger rival Dollar General Corp.. Dollar General's offer is "clearly superior" to Dollar Tree Inc's bid, Elliott said in a letter to Family Dollar's board and Chief Executive...